TransCode Therapeutics, Inc.
USD6.21
+0.97 (+18.51%)
CEO
Philippe Calais
IPO Date
2021-07-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.15
Prev. Close
$5.24
Day Low
$4.97
Day High
$6.30
52W Low
$3.82
52W High
$20.99
Market Cap
$0.01B
Volume
0.05M
| $0.00 |
| 18 Jun 2024 | Calais Philippe | director | A-Award | Acquired | 70,000 | $1.20 |
| 18 Jun 2024 | Marquet Magda | director | A-Award | Acquired | 70,000 | $1.20 |
| 19 May 2023 | Calais Philippe | director | A-Award | Acquired | 45,000 | $0.28 |
| 19 May 2023 | Marquet Magda | director | A-Award | Acquired | 45,000 | $0.28 |
| 10 May 2023 | Calais Philippe | director | A-Award | Acquired | 9,500 | $0.30 |
| 10 May 2023 | Marquet Magda | director | A-Award | Acquired | 9,500 | $0.30 |
| 22 Jun 2022 | Calais Philippe | director: | A-Award | Acquired | 9,500 | $0.00 |
| 22 Jun 2022 | Marquet Magda | director: | A-Award | Acquired | 9,500 | $0.00 |